Characteristic effects of anti-dementia drugs on rat sleep patterns

Journal of Pharmacological Sciences

Volumn 109, Issue 3, 2009, Pages 449-455

  Ishida, Takayuki ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Dementia; Donepezil; Galantamine; Memantine; Sleep wake pattern

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAM; FRONTAL CORTEX; MALE; NECK MUSCLE; NONHUMAN; NONREM SLEEP; RAT; REM SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SLEEP WAKING CYCLE;

ANIMALS; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; GALANTAMINE; INDANS; MALE; MEMANTINE; NOOTROPIC AGENTS; PIPERIDINES; RATS; RATS, WISTAR; SLEEP; SLEEP DISORDERS; SLEEP, REM;

EID: 67249084029     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08229FP     Document Type: Article

References (31)

1. Bliwise DL. Sleep disorders in Alzheimer's disease and other dementias. Clin Cornerstone. 2004;6:16-28.
2. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med. 2005;6:347-352.
3. Zivin M, Pregelj P. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system. Psychiatr Danub. 2008;20:168-173.
4. Lopes C, Pereira EF, Wu HQ, Purushottamachar P, Njar V, Schwarcz R, et al. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7*nicotinic receptors. J Pharmacol Exp Ther. 2007;322:48-58. (Pubitemid 46956368)
5. Wang D, Noda Y, Zhou Y, Mouri A, Mizoguchi H, Nitta A, et al. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacology. 2007;32:1261-1271. (Pubitemid 46788859)
6. Lerner AJ, McClendon MJ, Sami SA, Ogrocki PK, Adams KB, Smyth KA. Factors affecting usage patterns of memantine in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008,22:137-143.
7. Weller M, Finiels-Marlier F, Paul SM. NMDA receptor- mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amanta- dine and memantine. Brain Res. 1993;613:143-148. (Pubitemid 23280462)
8. Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis Assoc Disord. 2005;19:240-245.
9. Moraes WS, Poares DR, Guileminault C, Ramos LR, Bertolucci PH, Tufik SD. The effect of donepezil on sleep and REM sleep sleep EEG in patients with alzheimer disease: A double-blind placebo-controlled study. Sleep. 2006;29:199-205.
10. Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience. 2005;131:375-385.
11. Blesa R. Galantmaine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord. 2000;Suppl 1:28-34.
12. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 6th ed. San Doago: Academic Press; 2007.
13. Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci USA. 2001;98:9965-9970. (Pubitemid 32769411)
14. Shinomiya K, Shigemoto Y, Omichi J, Utsu Y, Mio M, Kamei C. Effects of three hypnotics on the sleep-wakefulness cycle in sleep-disturbed rats. Psychopharmacology (Berl). 2004;173:203-209. (Pubitemid 38591166)
15. Shinomiya K, Inoue T, Utsu Y, Tokunaga S, Masuoka T, Ohmori A, et al. Effects of kava-kava extract on the sleep-wake cycle in sleep-disturbed rats. Psychopharmacology (Berl). 2005;180:564-569. (Pubitemid 40905046)
16. Hirase M, Ishida T, Kamei C. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. Eur J Pharmacol. 2008;597:46-50.
17. Takeda Y, Ishida T, Tsutsui R, Tanimoto-Mori S, Watanabe S, Kanai Y, et al. Studies on somnolence in the daytime caused by drugs used for neuropathic pain. J Pharmacol Sci. 2008;107:246-250.
18. Yamada K, Takayanagi M, Kamei H, Nagai T, Dohniwa M, Kobayashi K, et al. Effects of memantine and donepezil on amyloid beta-induced memory impairment in a delayed- matching to position task in rats. Behav Brain Res. 2005;162: 191-199. (Pubitemid 40828531)
19. Chopin P, Briley M. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology (Berl). 1992;106:26-30.
20. Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol Biochem Behav. 2006;85:298-306.
21. Tokunaga S, Takeda Y, Shinomiya K, Hirase M, Kamei C. Effects of some H1-antagonists on the sleep-wake cycle in sleep disturbed rats. J Pharmacol Sci. 2007;103:201-206. (Pubitemid 46294652)
22. Schredl M, Weber B, Braus D, Gattaz WF, Berger M, Riemann D, et al. The effect of rivastigmine on sleep in elderly healthy subjects. Exp Gerontol. 2000;35:243-249. (Pubitemid 30190089)
23. Hedner J, Kraiczi J, Peker Y, Murphy P. Reduction of sleep- disordered breathing after physostigmine. Am J Respir Crit Care Med. 2003;168:1246-1251.
24. Markowitz JS, Gutterman EM, Lilienfeld S, Papadopoulos G. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep. 2003;26:602-606. (Pubitemid 39610654)
25. Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res. 2005;1033:186-193. (Pubitemid 40193413)
26. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Method Find Exp Clin Pharmacol. 2000;22:609-613. (Pubitemid 32171225)
27. Irifune M, Shimizu T, Nomoto M, Fukuda T. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol Biochem Behav. 1995;51:291-296.
28. Stone WS, Walker DL, Gold PE. Sleep deficits in rats after NMDA receptor blockade. Physiol Behav. 1992;52:609-612.
29. Spanagel R, Elibacher B, Wilke R. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur J Pharmacol. 1994;262:21-26. (Pubitemid 24271832)
30. Monti JM, Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev. 2007; 11:113-133. (Pubitemid 46330853)
31. Hanania T, Zahniser NR. Locomotor activity induced by non- competitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res. 2002;26:431-440.